Therapeutic Asset Ratings
329 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Sti-1492
Plasma Cell Myeloma
Sorrento Therapeutics, Inc.
P1
C
(36)
Taa-Specific Ctls
Plasma Cell Myeloma
Baylor College of Medicine
P1
C
(36)
tqb2029
Plasma Cell Myeloma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
P1
C
(36)
Tripril Car T Cells
Plasma Cell Myeloma
Marcela V. Maus, M.D.,Ph.D.
P1
C
(36)
Uf-Kure-Bcma Car T-Cells
Plasma Cell Myeloma
David Wald
P1
C
(36)
vp301
Plasma Cell Myeloma
Virtuoso BINco, Inc.
P1
C
(36)
Ws-Cart-Cs1
Plasma Cell Myeloma
Washington University School of Medicine
P1
C
(36)
Zirconium Zr 89-Dfo-Ys5
Plasma Cell Myeloma
Robert Flavell, MD, PhD
P1
C
(36)
Nex-20A
Plasma Cell Myeloma
Nanexa AB
Early P1
C
(36)
Magrolimab
Plasma Cell Myeloma
Gilead Sciences
P2
C
(35)
Itacitinib
Plasma Cell Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
C
(34)
64Cu-LLP2A
Plasma Cell Myeloma
Washington University School of Medicine
Early P1
C
(33)
[68Ga]Ga-R54
Plasma Cell Myeloma
National Cancer Institute, Naples
Early P1
C
(33)
68ga-nb381
Plasma Cell Myeloma
Peking University First Hospital
Early P1
C
(33)
68ga-pentixather
Plasma Cell Myeloma
Peking Union Medical College Hospital
Early P1
C
(33)
89zr-ny008
Plasma Cell Myeloma
Affiliated Hospital of Jiangnan University
Early P1
C
(33)
Bcma Targeted Car T-Cells
Plasma Cell Myeloma
The First Affiliated Hospital of Nanchang University
Early P1
C
(33)
car19-bcma dual-target car-t
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Early P1
C
(33)
cd19/cd20/bcma car-t
Multiple Myeloma
Shanghai Cell Therapy Group Co.,Ltd
Early P1
C
(33)
cd70-targeting car-t cells
Plasma Cell Myeloma
Zhejiang University
Early P1
C
(33)
Chimeric Antigen Receptor Nk Cell Targeting Bcma
Plasma Cell Myeloma
Shenzhen Pregene Biopharma Co., Ltd.
Early P1
C
(33)
Eso-T01
Plasma Cell Myeloma
Chunrui Li
Early P1
C
(33)
Gprc5D-Car-T
Plasma Cell Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Early P1
C
(33)
Human Bcma Targeted Car-Nk Cells
Plasma Cell Myeloma
Hrain Biotechnology Co., Ltd.
Early P1
C
(33)
Human Derived Anti-Bcma Car-T
Plasma Cell Myeloma
Hrain Biotechnology Co., Ltd.
Early P1
C
(33)
Showing 276 to 300 of 329 assets
Previous
Page 12 of 14
Next
